RYOIX - Rydex Biotechnology Inv

Nasdaq - Nasdaq Delayed Price. Currency in USD
95.88
+1.31 (+1.39%)
At close: 4:50PM EST
Stock chart is not supported by your current browser
Previous Close94.57
YTD Return29.73%
Expense Ratio (net)1.37%
CategoryHealth
Morningstar Rating★★★☆☆
Morningstar Risk RatingHigh
Last Cap Gain0.00
Net Assets322.4M
Beta (3y)1.37
Yield0.00%
Holdings Turnover207.00%
Last Dividend0.00
Inception DateApr 1, 1998
Average for CategoryN/A
  • We're sorry we weren't able to find anything about this topic.